These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 17714062)
21. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists. Mitoma H; Horiuchi T; Tsukamoto H; Ueda N Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553 [TBL] [Abstract][Full Text] [Related]
22. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750 [TBL] [Abstract][Full Text] [Related]
23. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Kievit W; Fransen J; Oerlemans AJ; Kuper HH; van der Laar MA; de Rooij DJ; De Gendt CM; Ronday KH; Jansen TL; van Oijen PC; Brus HL; Adang EM; van Riel PL Ann Rheum Dis; 2007 Nov; 66(11):1473-8. PubMed ID: 17426065 [TBL] [Abstract][Full Text] [Related]
24. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases]. Fautrel B; Cherin P Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396 [TBL] [Abstract][Full Text] [Related]
25. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective. Meroni PL; Valesini G BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Hochberg MC; Tracy JK; Hawkins-Holt M; Flores RH Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii13-6. PubMed ID: 14532140 [TBL] [Abstract][Full Text] [Related]
27. Treatment of rheumatoid arthritis by TNF-blocking agents. Graninger W; Smolen J Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849 [TBL] [Abstract][Full Text] [Related]
28. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242 [TBL] [Abstract][Full Text] [Related]
29. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195 [TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis. Hamilton K; Clair EW Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494 [TBL] [Abstract][Full Text] [Related]
34. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491 [TBL] [Abstract][Full Text] [Related]
35. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. Keating GM; Perry CM BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept]. Tijhuis GJ; van de Putte LB; Breedveld FC Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312 [TBL] [Abstract][Full Text] [Related]
37. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Feldmann M; Maini RN Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034 [TBL] [Abstract][Full Text] [Related]